{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T11:43:55Z","timestamp":1783338235601,"version":"3.54.6"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T00:00:00Z","timestamp":1697068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T00:00:00Z","timestamp":1697068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s40123-023-00826-6","type":"journal-article","created":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T12:02:33Z","timestamp":1697112153000},"page":"3337-3345","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["10-Year Outcomes of Pediatric Cataract Surgery with Foldable Intraocular Lens Implantation and Posterior Continuous Curvilinear Capsulorhexis"],"prefix":"10.1007","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9071-7018","authenticated-orcid":false,"given":"Tetsuro","family":"Oshika","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaku","family":"Kiuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,12]]},"reference":[{"key":"826_CR1","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1016\/j.survophthal.2022.03.005","volume":"67","author":"PD Lenhart","year":"2022","unstructured":"Lenhart PD, Lambert SR. Current management of infantile cataracts. Surv Ophthalmol. 2022;67:1476\u2013505.","journal-title":"Surv Ophthalmol"},{"key":"826_CR2","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1016\/j.ophtha.2020.04.046","volume":"127","author":"DA Plager","year":"2020","unstructured":"Plager DA, Bothun ED, Freedman SF, Wilson ME, Lambert SR. Complications at 10 years of follow-up in the Infant Aphakia Treatment Study. Ophthalmology. 2020;127:1581\u20133.","journal-title":"Ophthalmology"},{"key":"826_CR3","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1177\/1120672119862878","volume":"30","author":"M Murphy","year":"2020","unstructured":"Murphy M, Murtagh P, McAnena L, Eldouri A, Kirwan C, O\u2019Keefe M. Secondary glaucoma and visual axis opacification in aphakic and pseudophakic patients following congenital cataract surgery: a 28-year longitudinal case series. Eur J Ophthalmol. 2020;30:1370\u201380.","journal-title":"Eur J Ophthalmol"},{"key":"826_CR4","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1097\/j.jcrs.0000000000000482","volume":"47","author":"SK McClatchey","year":"2021","unstructured":"McClatchey SK, McClatchey TS, Cotsonis G, Nizam A, Lambert SR, Infant Aphakia Treatment Study Group. Refractive growth variability in the Infant Aphakia Treatment Study. J Cataract Refract Surg. 2021;47:512\u20135.","journal-title":"J Cataract Refract Surg"},{"key":"826_CR5","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1097\/ICL.0000000000000718","volume":"47","author":"SR Lambert","year":"2021","unstructured":"Lambert SR, Nizam A, DuBois L, Cotsonis G, Weakley DR Jr, Wilson ME, Infant Aphakia Treatment Study Group. The myopic shift in aphakic eyes in the Infant Aphakia Treatment Study after 10 years of follow-up. Eye Contact Lens. 2021;47:108\u201312.","journal-title":"Eye Contact Lens"},{"key":"826_CR6","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1001\/jamaophthalmol.2020.5664","volume":"139","author":"SF Freedman","year":"2021","unstructured":"Freedman SF, Beck AD, Nizam A, Vanderveen DK, Plager DA, Morrison DG, Drews-Botsch CD, Lambert SR, Infant Aphakia Treatment Study Group. Glaucoma-related adverse events at 10 years in the infant aphakia treatment study: a secondary analysis of a randomized clinical trial. JAMA Ophthalmol. 2021;139:165\u201373.","journal-title":"JAMA Ophthalmol"},{"key":"826_CR7","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.ophtha.2022.04.004","volume":"129","author":"DR Weakley Jr","year":"2022","unstructured":"Weakley DR Jr, Nizam A, VanderVeen DK, Wilson ME, Kruger S, Lambert SR, Infant Aphakia Treatment Study Group. Myopic shift at 10-year follow-up in the Infant Aphakia Treatment Study. Ophthalmology. 2022;129:1064\u20135.","journal-title":"Ophthalmology"},{"key":"826_CR8","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3928\/0191-3913-19960701-06","volume":"33","author":"S Awner","year":"1996","unstructured":"Awner S, Buckley EG, DeVaro JM, Seaber JH. Unilateral pseudophakia in children under 4 years. J Pediatr Ophthalmol Strabismus. 1996;33:230\u20136.","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"826_CR9","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1136\/bjophthalmol-2014-306394","volume":"99","author":"AL Solebo","year":"2015","unstructured":"Solebo AL, Russell-Eggitt I, Cumberland PM, Rahi JS, British Isles Congenital Cataract Interest Group. Risks and outcomes associated with primary intraocular lens implantation in children under 2 years of age: the IoLunder2 cohort study. Br J Ophthalmol. 2015;99:1471\u20136.","journal-title":"Br J Ophthalmol"},{"key":"826_CR10","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/ICU.0000000000000516","volume":"29","author":"A Thau","year":"2018","unstructured":"Thau A, Lloyd M, Freedman S, Beck A, Grajewski A, Levin AV. New classification system for pediatric glaucoma: implications for clinical care and a research registry. Curr Opin Ophthalmol. 2018;29:385\u201394.","journal-title":"Curr Opin Ophthalmol"},{"key":"826_CR11","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1001\/jamaophthalmol.2019.4571","volume":"138","author":"SF Freedman","year":"2020","unstructured":"Freedman SF, Kraker RT, Repka MX, Wallace DK, de Alba Campomanes A, Yanovitch TL, Orge FH, Gearinger MD, Pediatric Eye Disease Investigator Group (PEDIG). Incidence and management of glaucoma or glaucoma suspect in the first year after pediatric lensectomy. JAMA Ophthalmol. 2020;138:71\u20135.","journal-title":"JAMA Ophthalmol"},{"key":"826_CR12","first-page":"1532","volume":"37","author":"EE Birch","year":"1996","unstructured":"Birch EE, Stager DR. The critical period for surgical treatment of dense congenital unilateral cataract. Invest Ophthalmol Vis Sci. 1996;37:1532\u20138.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"826_CR13","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/S0002-9394(14)77377-5","volume":"93","author":"SS Gelbart","year":"1982","unstructured":"Gelbart SS, Hoyt CS, Jastrebski G, Marg E. Long-term visual results in bilateral congenital cataracts. Am J Ophthalmol. 1982;93:615\u201321.","journal-title":"Am J Ophthalmol"},{"key":"826_CR14","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jaapos.2005.10.002","volume":"10","author":"SR Lambert","year":"2006","unstructured":"Lambert SR, Lynn MJ, Reeves R, Plager DA, Buckley EG, Wilson ME. Is there a latent period for the surgical treatment of children with dense bilateral congenital cataracts? J AAPOS. 2006;10:30\u20136.","journal-title":"J AAPOS"},{"key":"826_CR15","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jaapos.2008.07.010","volume":"13","author":"EE Birch","year":"2009","unstructured":"Birch EE, Cheng C, Stager DR Jr, Weakley DR Jr, Stager DR Sr. The critical period for surgical treatment of dense congenital bilateral cataracts. J AAPOS. 2009;13:67\u201371.","journal-title":"J AAPOS"},{"key":"826_CR16","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1001\/jamaophthalmol.2021.6176","volume":"140","author":"MX Repka","year":"2022","unstructured":"Repka MX, Dean TW, Kraker RT, Li Z, Yen KG, de Alba Campomanes AG, Young MP, Rahmani B, Haider KM, Whitehead GF, Lambert SR, Kurup SP, Kraus CL, Cotter SA, Holmes JM, Pediatric Eye Disease Investigator Group. Visual acuity and ophthalmic outcomes 5 years after cataract surgery among children younger than 13 years. JAMA Ophthalmol. 2022;140:269\u201376.","journal-title":"JAMA Ophthalmol"},{"issue":"8","key":"826_CR17","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1001\/jamaophthalmol.2023.2335","volume":"141","author":"KG Yen","year":"2023","unstructured":"Yen KG, Repka MX, Sutherland DR, Haider KM, Hatt SR, Kraker RT, Galvin JA, Li Z, Cotter SA, Holmes JM, Pediatric Eye Disease Investigator Group. Complications occurring through 5 years following primary intraocular lens implantation for pediatric cataract. JAMA Ophthalmol. 2023;141(8):705\u201314.","journal-title":"JAMA Ophthalmol"},{"key":"826_CR18","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1001\/jamaophthalmol.2022.6413","volume":"141","author":"ED Bothun","year":"2023","unstructured":"Bothun ED, Repka MX, Kraker RT, Wu R, Leske DA, Hatt SR, Li Z, Freedman SF, Astle WF, Cotter SA, Holmes JM, Pediatric Eye Disease Investigator Group. Incidence of glaucoma-related adverse events in the first 5 years after pediatric lensectomy. JAMA Ophthalmol. 2023;141:324\u201331.","journal-title":"JAMA Ophthalmol"},{"key":"826_CR19","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2023.2672","author":"Y Liu","year":"2023","unstructured":"Liu Y. Some lessons regarding intraocular implantation following pediatric cataract surgery. JAMA Ophthalmol. 2023. https:\/\/doi.org\/10.1001\/jamaophthalmol.2023.2672.","journal-title":"JAMA Ophthalmol"},{"key":"826_CR20","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S1091-8531(00)90009-0","volume":"4","author":"S Asrani","year":"2000","unstructured":"Asrani S, Freedman S, Hasselblad V, Buckley EG, Egbert J, Dahan E, Gimbel H, Johnson D, McClatchey S, Parks M, Plager D, Maselli E. Does primary intraocular lens implantation prevent \u201caphakic\u201d glaucoma in children? J AAPOS. 2000;4:33\u20139.","journal-title":"J AAPOS"},{"key":"826_CR21","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.jcjo.2019.01.003","volume":"54","author":"R Yagev","year":"2019","unstructured":"Yagev R, Khatib N, Barrett C, Lior Y, Lifshitz T, Tsumi E. Intraocular lens implantation as an isolated risk factor for secondary glaucoma in pediatric patients. Can J Ophthalmol. 2019;54:621\u20135.","journal-title":"Can J Ophthalmol"},{"key":"826_CR22","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/s41433-018-0316-8","volume":"33","author":"S Balekudaru","year":"2019","unstructured":"Balekudaru S, Agarkar S, Guha S, Mayee RC, Viswanathan N, Pandey A, Singh M, Lingam V, George R. Prospective analysis of the predictors of glaucoma following surgery for congenital and infantile cataract. Eye (Lond). 2019;33:796\u2013803.","journal-title":"Eye (Lond)"},{"key":"826_CR23","doi-asserted-by":"publisher","DOI":"10.1136\/bjo-2022-322589","author":"J Wang","year":"2023","unstructured":"Wang J, Wu X, Wang Q, Zhou F, Chen H, Chen W, Lin D, Zhang X, Wang R, Chen J, Liu Z, Lin Z, Li X, Li J, Han Y, Liu Y, Lin H, Chen W. Incidence of and risk factors for suspected and definitive glaucoma after bilateral congenital cataract surgery: a 5-year follow-up. Br J Ophthalmol. 2023. https:\/\/doi.org\/10.1136\/bjo-2022-322589.","journal-title":"Br J Ophthalmol"},{"key":"826_CR24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ajo.2018.06.005","volume":"193","author":"AR Vasavada","year":"2018","unstructured":"Vasavada AR, Vasavada V, Shah SK, Praveen MR, Vasavada VA, Trivedi RH, Rawat F, Koul A. Five-year postoperative outcomes of bilateral aphakia and pseudophakia in children up to 2 years of age: a randomized clinical trial. Am J Ophthalmol. 2018;193:33\u201344.","journal-title":"Am J Ophthalmol"},{"key":"826_CR25","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/S2352-4642(18)30317-1","volume":"2","author":"AL Solebo","year":"2018","unstructured":"Solebo AL, Cumberland P, Rahi JS, British Isles Congenital Cataract Interest Group. 5-year outcomes after primary intraocular lens implantation in children aged 2 years or younger with congenital or infantile cataract: findings from the IoLunder2 prospective inception cohort study. Lancet Child Adolesc Health. 2018;2:863\u201371.","journal-title":"Lancet Child Adolesc Health"},{"key":"826_CR26","doi-asserted-by":"publisher","first-page":"22","DOI":"10.12809\/hkmj209241","volume":"29","author":"JJT Chan","year":"2023","unstructured":"Chan JJT, Wong ES, Lam CPS, Yam JC. Ten-year refractive and visual outcomes of intraocular lens implantation in infants with congenital cataract. Hong Kong Med J. 2023;29:22\u201330.","journal-title":"Hong Kong Med J"},{"key":"826_CR27","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.ophtha.2016.12.040","volume":"124","author":"DR Weakley Jr","year":"2017","unstructured":"Weakley DR Jr, Lynn MJ, Dubois L, Cotsonis G, Wilson ME, Buckley EG, Plager DA, Lambert SR, Infant Aphakia Treatment Study Group. Myopic shift 5 years after intraocular lens implantation in the Infant Aphakia Treatment Study. Ophthalmology. 2017;124:822\u20137.","journal-title":"Ophthalmology"},{"key":"826_CR28","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1159\/000442498","volume":"57","author":"SR Lambert","year":"2016","unstructured":"Lambert SR. Changes in ocular growth after pediatric cataract surgery. Dev Ophthalmol. 2016;57:29\u201339.","journal-title":"Dev Ophthalmol"},{"key":"826_CR29","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1067\/mpa.2001.119786","volume":"5","author":"ME Wilson","year":"2001","unstructured":"Wilson ME, Elliott L, Johnson B, et al. AcrySof acrylic intraocular lens implantation in children: clinical indications of biocompatibility. J Am Assoc Pediatr Ophthalmol Strabismus. 2001;5:377\u201380.","journal-title":"J Am Assoc Pediatr Ophthalmol Strabismus"},{"key":"826_CR30","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s00417-003-0722-9","volume":"241","author":"M K\u00fcchle","year":"2003","unstructured":"K\u00fcchle M, Lausen B, Gusek-Schneider GC. Results and complications of hydrophobic acrylic vs PMMA posterior chamber lenses in children under 17 years of age. Graefes Arch Clin Exp Ophthalmol. 2003;241:637\u201341.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"826_CR31","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.jaapos.2003.07.004","volume":"7","author":"AR Vasavada","year":"2003","unstructured":"Vasavada AR, Nath VC, Trivedi RH. Anterior vitreous face behavior with AcrySof in pediatric cataract surgery. J Am Assoc Pediatr Ophthalmol Strabismus. 2003;7:384\u20138.","journal-title":"J Am Assoc Pediatr Ophthalmol Strabismus"},{"key":"826_CR32","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1136\/bjo.2003.023275","volume":"88","author":"N Rowe","year":"2004","unstructured":"Rowe N, Biswas S, Lloyd I. Primary IOL implantation in children: a risk analysis of foldable acrylic v PMMA lenses. Br J Ophthalmol. 2004;88:481\u20135.","journal-title":"Br J Ophthalmol"},{"key":"826_CR33","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.joco.2018.11.005","volume":"31","author":"M Mohammadpour","year":"2018","unstructured":"Mohammadpour M, Shaabani A, Sahraian A, Momenaei B, Tayebi F, Bayat R, Mirshahi R. Updates on managements of pediatric cataract. J Curr Ophthalmol. 2018;31:118\u201326.","journal-title":"J Curr Ophthalmol"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-023-00826-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-023-00826-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-023-00826-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T07:20:35Z","timestamp":1699687235000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-023-00826-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,12]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["826"],"URL":"https:\/\/doi.org\/10.1007\/s40123-023-00826-6","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,12]]},"assertion":[{"value":"13 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Tetsuro Oshika received compensation as a consultant from Alcon, Johnson & Johnson Vision, Santen Pharmaceutical, HOYA, Topcon, and Logic and Design. He receives research support from Santen Pharmaceutical, Tomey, Alcon, Senju Pharmaceutical, Johnson & Johnson Vision, HOYA, KOWA Pharmaceutical, Otsuka Pharmaceutical, Novartis, Topcon, Tomey, and Chugai Pharmaceutical. Dr. Gaku Kikuchi does not have any conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study was conducted in adherence to the tenets of the Declaration of Helsinki, and the institutional review board of Tsukuba University Hospital approved the study protocol (R04-162, December 2022). The institutional review board of Tsukuba University Hospital committee waived the need for patient informed consent for the use of their medical record data, in line with the regulations of the Japanese Guidelines for Epidemiologic Study issued by the Japanese Government. Due to the observational nature of the study, clinical trial registration was not mandated.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}